microdosing glp-1 inflammation Curious if is right for you? Microdosing GLP-1 is a great way to support appetite control, reduce cravings, quiet food noise, and help the body feel more balanced. Think steady Microdosing GLP-1 and Inflammation: A

Approved indications for GLP-1s: Cardiovascular disease Chronic kidney disease Obesity Sleep apnea Type 2 diabetes Metabolic dysfunction-associated steatohepatitis (MASH) Potential future indications: (indications with asterisks have already been investigated in randomized clinical trials) Substance use disorders (alcohol, tobacco) Alzheimers Parkinsons Cancer prevention Diabetes prevention* Diabetic retinopathy Heart failure* Osteoarthritis* Peripheral artery disease* Polycystic ovarian syndrome Psoriasis When I was at the ADAs 85th Scientific Sessions this year, what was quite apparent was just how quickly the field has progressed beyond GLP-1s

Plasma levels of OXA are increased during fasting in humans (32) and are lower in obese subjects than normal-weight people (33), suggesting that peripheral OXA modulates food intake as an orexigenic peptide (34)

Studies have shown that a well-structured exercise program improves balance and coordination which contribute to a lower incidence of injuries

neuroimaging features (1) The most common finding is T2/FLAIR hyperintensity with strongly restricted diffusion affecting gyri in the parieto-occipital and temporal regions.(31589567) (2) Basal ganglia can be involved, which may be a poor prognostic sign.(31589567) (3) Characteristically, there is sparing of the thalami, white matter, and cerebellum